Journal of Postgraduate Medicine
 Open access journal indexed with Index Medicus & ISI's SCI  
Users online: 2127  
Home | Subscribe | Feedback | Login 
About Latest Articles Back-Issues Articlesmenu-bullet Search Instructions Online Submission Subscribe Etcetera Contact
 
  NAVIGATE Here 
  Search
 
 :: Next article
 :: Previous article 
 :: Table of Contents
  
 RESOURCE Links
 ::  Similar in PUBMED
 ::  Search Pubmed for
 ::  Search in Google Scholar for
 ::Related articles
 ::  [PDF Not available] *
 ::  Citation Manager
 ::  Access Statistics
 ::  Reader Comments
 ::  Email Alert *
 ::  Add to My List *
* Registration required (free) 

  IN THIS Article
 ::  Abstract
 ::  Introduction
 ::  Material and methods
 ::  Results
 ::  Discussion
 ::  References
 ::  Article Tables

 Article Access Statistics
    Viewed6851    
    Printed231    
    Emailed3    
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 1    

Recommend this journal


 


 
Year : 1989  |  Volume : 35  |  Issue : 1  |  Page : 20-3

Prevalence of antibodies to aspergilli in bronchial asthmatics.




Correspondence Address:
A A Kumar


Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 0002585333

Rights and PermissionsRights and Permissions


 :: Abstract 

Sputum and bleed samples were analysed from 330 cases of bronchial asthmatics and 50 normal persons without features of bronchial asthma. The prevalence of aspergilli and antibodies to different Aspergillus species were detected using cultural methods and serological technique like agar gel double diffusion (DD), counter-immuno-electrophoresis (CIEP) and enzyme-linked immunosorbent assay (ELISA). Out of total 6.06% yielded Aspergillus species in sputum specimens repeatedly. Precipitins against Aspergillus species were detected in 7.88% of cases by DD and CIEP. ELISA test showed 20% of cases to be having antibodies to A. fumigatus. Allergic broncho-pulmonary aspergillosis can be detected in the early course of the disease in bronchial asthmatics using highly sensitive technique like ELISA.


Keywords: Antibodies, analysis,Aspergillosis, Allergic Bronchopulmonary, diagnosis,Aspergillus, immunology,Asthma, blood,immunology,Human, Sputum, analysis,immunology,


How to cite this article:
Kumar A A, Sahu R C, Subbannayyar K K, Jyothirlata, Rau P V, Shivananda P G. Prevalence of antibodies to aspergilli in bronchial asthmatics. J Postgrad Med 1989;35:20

How to cite this URL:
Kumar A A, Sahu R C, Subbannayyar K K, Jyothirlata, Rau P V, Shivananda P G. Prevalence of antibodies to aspergilli in bronchial asthmatics. J Postgrad Med [serial online] 1989 [cited 2023 Jun 8];35:20. Available from: https://www.jpgmonline.com/text.asp?1989/35/1/20/5730





 :: Introduction Top


The members of the genus Aspergillus form an important group of pathogens of the broncho-pulmonary system. The spectrum of diseases caused by them encompasses aspergilloma, chronic necrotising pulmonary aspergillosis, invasive pulmonary aspergillosis, allergic broncho-pulmonary aspergillosis (ABPA), bronchial asthma and allergic alveolitis.[13] The association between asthma and aspergilli was noted as early as in 1925.[3] Investigations have confirmed that Aspergillus spores are more common in the sputum of patients with asthma than with other lung disorders.[3],[4]

The present study was carried out to find out the prevalence of aspergilli and antibodies to Aspergillus species in bronchial asthmatics using cultural methods and serological techniques like agar gel double diffusion, counter-immuno-electrophoresis and enzyme-linked immunosorbest assay.


 :: Material and methods Top


Subjects

Sputum and blood samples were collected from 330 cases of bronchial asthma. These cases were selected from patients with various lung disorders attending the Pulmonary Tuberculosis and Chest Diseases Department of Kasturba Medical College Hospital, Manipal. The proven ABPA cases were excluded out of the study. The cases were subjected to routine blood examination, pulmonary function tests, absolute eosinophil count, immunoglobulin profile and bronchogram. Fifty normal persons without any features of bronchial asthma or any other lung complaints were included as controls.

Sputum culture

Early morning sputum samples were collected from these cases on 3 consecutive days. After gross examination, the sputum samples were subjected to direct microscopy using KOH mounts, Gram's and Ziehl-Neelsen staining techniques. The smears were examined for fungal elements. The sputum samples were then inoculated into Sabouraud's dextrose agar slants with chloramphenicol (0.05 mg/ml) in duplicate. The tubes were incubated at room temperature and 37°C. Examination of the tubes was done regularly for upto 10 days of incubation and the aspergilli grown if any were subcultured onto Czapek-Dox synthetic agar medium. The macro and microscopic characters of fungal colonies were studied as per Raper and Fennell.[12]

Serum samples

Serum samples collected from the patients were preserved at -70°C until further testing.

Antigen preparation

Antigens were prepared from A. fumigatus, A. niger and A. flavus species isolated from the sputum of patients. The preparation of antigens was done according to Kurup et al.[5],[6] The protein and carbohydrate content of the antigens were determined using standard methods.[2],[7]

Agar gel double diffusion (D) :

The antigen-antibody interactions were carried out using DD technique according to the modified method of Wadsworth.[15] The antigens were used at a protein concentration of 10 mg/ml.[5]

Counter-immunoelectrophoresis (CIEP) :

The CIEP test was performed as per the method of Warnock using antigens at a protein concentration of 5 mg/ml.[16]

Enzyme-linked immunosorbent assay (ELISA ) :

The culture filtrate antigen of A. fumigatus only was used as antigen in ELISA test. The antigen containing 40-50 µg protein/ml, in carbonate buffer (0.05 M, pH 9.6), was used to coat the wells of the micrititer plates (Dynatech MicroELISA systems, Germany).[6] The concentration of the antigen and conjugate were determined by means of checkerboard titrations using positive and negative sera.

One hundred µl of the antigen was added to each well of the micro-ELISA plate and was incubated at 4°C for 18 hours. The wells were washed 3 times with phosphate buffered saline (PBS, 0.01M, pH 7.2) containing 0.05% Tween-20 (PBS-Tween). Serum dilutions ranging from 1:50 to 1:6400 were done in PBS-Tween, added to each well and the plate was incubated for 2 hours at 37°C. Then the plate was washed 3 times with PBS-Tween. One hundred µl of 1:1000 dilution of goat antihuman gammaglobulin conjugated with horseradishperoxidase (Sigma Chemical Co., U.S.A.) was added to each well. The plate was incubated at 37°C for 2 hours and was washed 3 times with PBS-Tween. One hundred µl of substate and chromogen (0.01% H202, 0.05% 0-Phenylenediamine) in citrate phosphate buffer (pH 5.0) were added to each well. The plate was incubated in the dark at room temperature for 30 minutes. The reaction was stopped by the addition of 100 0 of 0.5N H2S04. The results were read visually as well as photometrically at 490 nm using a Dynatech MicroELISA reader. The test was considered positive with optical density (O.D.) of 0.30 or above. This cut-off value was obtained by taking 2 standard deviations (S.D. 2 x 0.041) above the mean value (0.223) in healthy normal subjects.


 :: Results Top


Results of the cultural and serological studies are shown in[Table - 1]. Out of the 330 cases studied, 20 cases (6.06%) yielded Aspergillus species in sputum samples repeatedly. Among the Aspergillus isolates, 12 were Aspergillus fumigatus (3.64%), 5 were A. niger (1.5%) and 3 were A. flavus (0.91%). Precipitins to Aspergillus species were detected in 26 cases (7.88%) both by DD and CIEP. ELISA test showed comparatively higher number of persons to be having antibodies to A. fumigatus (20%). Of the normal persons, sputum sample of only one case (2%) yielded A. fumigatus repeatedly. The serum sample of the same patient showed positive serology to A. fumigatus by DD, CIEP and ELISA test and all other serum samples were negative for antibodies to Aspergilli.


 :: Discussion Top


The genus Aspergillus is one of the most ubiquitous of all micro-organisms. Its approximately 150 species are common to soil, water and decaying vegetation throughout the world. Studies have shown that aspergilli have a significant potential to act as powerful allergens in the human respiratory tract.[9],[11] Depending on an individual's proclivity to develop allergy, and the setting, intensity and duration of a given aspergillus exposure, a variety of diverse, yet intimately related hypersensitivity syndromes may develop.[1]

ABPA has been defined as a condition which usually presents as an acute, easily reversible asthmatic syndrome in a very atopic individual. Depending on the type of antigen used, the prevalence of precipitin antibodies to Aspergilli have been found to vary from 2.5% to 13.5% of bronchial asthmatics.[8] In our study, the precipitins have been found in 7.88% of the cases. These findings agree with some of the earlier studies.[10],[14] In the present series of asthmatics, proven by history, clinical examination and pulmonary function studies. routine chest X-ray revealed no abnormalities or features suggestive of hyperinflation. As the presence of asthma is the usual feature of ABPA, some of the asthmatics may become potential candidates for ABPA after the onset of asthma and hence require long term follow up. With the employment of a highly sensitive technique like ELISA, antibodies to Aspergilli may be detected in more number of cases in this specific group of patients. This fact has been substantiated by our findings, where ELISA has shown antibodies to A. fumigatus in 20% of asthmatics whereas DD and CIEP detected precipitins in only 7.88% of cases. Therefore, bronchial asthmatics should be subjected to serological diagnosis of ABPA using a highly sensitive technique like ELISA. This serves as a useful aid in the diagnosis of the possibility of ABPA in the early cause of bronchial asthma.



 
 :: References Top

1.Bardana, E. J. Jr.: The Clinical spectrum of aspergillosis-Part 2: classification and description of saprophytic, allergic and invasive variants of human disease. Crit. Rev. Clin. Lab. Sci., 13: 85-159, 1980.   Back to cited text no. 1    
2.Dubois, M., Giles, A., Hamilton, J. K., Rebers, P. A. and Smith, F.: Colorimetric method for determination of sugars and related substances. Anal. Chem., 28: 350-356, 1956.  Back to cited text no. 2    
3.Henderson, A. H.: Allergic aspergillosis: Review of 32 cases. Thorax., 23: 501-512, 1968.  Back to cited text no. 3    
4.Henderson, A. H., English, M. P. and Vecht, R. J.: Pulmonary aspergillosis. A survey of its occurrence in patients with chronic lung disease and a discussion of the significance of diagnostic tests. Thorax. 23: 513-518, 1968.  Back to cited text no. 4    
5.Kurup, V. P., Fink, J. N., Scribner, G H. and Falk, M. J.: Antigenic variability of Aspergillus fumigatus strains. Microbics, 19: 191-204, 1977.  Back to cited text no. 5    
6.Kurup, V. P., Resnick, A., Scribner, G. H., Kalbfleisch, J. H. and Fink, J. N.: Comparison of antigens and serological methods in Aspergillus fumigatus antibody detection. Mykosen, 27: 43-50, 1984.  Back to cited text no. 6    
7.Lowry, O. H., Rosebrough, N. J., Farr A. L. and Randall, R. J.: Protein measurement with Folin-Phenol reagent, J. Biol. Chem., 193: 265-275, 1951/1952.   Back to cited text no. 7    
8.Malo, J. L., Paquin, R. and Longbottom, J. L.: Prevalence of precipitating antibodies to different extracts of Aspergillus fumigatus in a North American asthmatic population, Clin. Allergy, 11: 333-341, 1981.  Back to cited text no. 8    
9.McCarthy, D. S. and Pepys, J.: Pulmonary aspergilloma-clinical immunology Clin. Allergy, 3: 57-70, 1973.  Back to cited text no. 9    
10.Mearns, M., Longbottom, J. and Batten, J.: Precipitating antibodies to Aspergillus jumigatus in cystic fibrosis. Lancet, 1: 538-539, 1967.  Back to cited text no. 10    
11.Patterson, R., Rosenberg, M. and Roberts, M.: Evidence that Aspergillus fumigatus growing in the airway of man can be a potent stimulus of specific and nonspecific IgE formation. Amer. J. Med., 63: 257-262, 1977.  Back to cited text no. 11    
12.Raper, K. B. and Fennell, D. I.: "The genus Aspergillus", 1st edition, Williams and Wilkins Co., Baltimore, 1965, pp. 238-404.  Back to cited text no. 12    
13.Schonheyder, H.: Pathogenetic and serological aspects of pulmonary aspergillosis. Scand. J. Inf. Dis. (Suppl.), 51: 1-62, 1987.  Back to cited text no. 13    
14.Schwartz, P. B., Citron, K. M., Chester, E. H.. Kaimal, J., Barlow, P. B., Baum, G. L. and Schuyler, M. R.: A comparison of the prevalence of sensitization to Aspergillus antigens among asthmatics in Cleveland and London. J. Allergy & Clip. Immunol., 62: 9-14, 1978.  Back to cited text no. 14    
15.Wadsworth, C.: A microtemplate employing a gel chamber compared with other micro-and macrotemplate for immunodiffusion. Int. Arch. Allergy, 21: 131-137, 1962.  Back to cited text no. 15    
16.Warnock, D. W.: Detection of Aspergillus funzigatus precipitins: a comparison of counter immunoelectrophoresis and double diffusion. J. Clin. Pathol., 30: 388-389, 1977.  Back to cited text no. 16    


    Tables

[Table - 1]

This article has been cited by
1 Bronchopulmonary aspergillosis: new developments
Germaud P, Renaudin K, Danner I, et al.
REVUE DES MALADIES RESPIRATOIRES. 2001; 18 (3): 257-266
[Pubmed]



 

Top
Print this article  Email this article
Previous article Next article
Online since 12th February '04
© 2004 - Journal of Postgraduate Medicine
Official Publication of the Staff Society of the Seth GS Medical College and KEM Hospital, Mumbai, India
Published by Wolters Kluwer - Medknow